ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00726869
Brief Title: A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies.

First Submitted : July 29, 2008
First Submitted that Met QC Criteria : July 30, 2008
First Posted : August 1, 2008 (Estimate)

Last Update Submitted that Met QC Criteria : August 22, 2012
Last Update Posted : August 23, 2012 (Estimate)